Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that ...

CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

The embryo-like model could help scientists test new drugs, create stem cells for transplants and research blood disorders ...

The team used human stem cells to create embryo-like structures dubbed “hematoids” that mirror some features of early human ...

Nutrition experts share the best time to take vitamin B, plus who should be supplementing, how much you need, and what all ...

Researchers uncover how cells develop and specialize, advancing prospects for regenerative dental treatments. Researchers at ...

This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular senescence, and tissue degeneration. By dissecting B-cell dysfunction, ...

Upcoming safety data release expected to also highlight favorable tolerability profile observed to date and ease-of-use of the regimen that includes cyclophosphamide/fludarabine conditioning, and ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies ...

Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. /CNW/ — Equity InsiderNews Commentary – MIT and Harvard scientists recently created engineered ...